Analysts at HC Wainwright increased their Q1 2025 earnings estimates for shares of REGENXBIO in a note issued to investors on ...
Novartis announces positive data from phase III study of intrathecal onasemnogene abeparvovec in broad patient population with SMA: Basel Friday, March 21, 2025, 11:00 Hrs [IST] N ...
Stocktwits on MSN14h
Sarepta Therapeutics Stock Has A Nightmarish Week After DMD Patient Death, But Retail And Analysts Aren't Giving UpShares of Sarepta Therapeutics Inc. have lost more than 26% this week, heading for their worst such performance in over a ...
IBM (NYSE: IBM) announced the Asia Pacific geography winners of the 2025 IBM Partner Plus Awards, which celebrate IBM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback